This could be achieved by integrating primary neuronal cultures and brain organoid models derived from AD patients, which can mimic the brain’s three-dimensional microenvironment and cellular heterogeneity, as well as AD animal models, such as APP/PS1 transgenic mice. Here, APP is linked to Alzheimer disease.